Global Product Portfolio

Below is a list of the treatments we currently offer via our Innovative Medicines Division. Visit Sandoz and Advanced Accelerator Applications to learn about our generics and radiopharmaceutical products.
Please note: Not all treatments are available in all countries.

A B C D E F G I J K L M N O P R S T U V X Z

brinzolamide

Azarga®/Azorga®

brinzolamide, timolol
Ophthalmology
Ophthalmology
Germany Australia Austria Poland Netherlands Canada Japan

erenumab

Aimovig®

erenumab
Neuroscience
Neuroscience
USA Product Site USA

everolimus

Afinitor Disperz®/Votubia®

everolimus
Oncology
Oncology
Global Product Site USA Product Site USA Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Netherlands Canada Turkey

Afinitor®/Votubia®

everolimus
Oncology
Oncology
Global Product Site USA Product Site USA Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Netherlands Canada Turkey

ofatumumab

Arzerra®

ofatumumab
Oncology
Oncology
Global Product Site USA Product Site USA Finland Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Netherlands Canada Turkey Japan

timolol

Azarga®/Azorga®

brinzolamide, timolol
Ophthalmology
Ophthalmology
Germany Australia Austria Poland Netherlands Canada Japan